Index of reports
> Cases with Aplasia (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) where reactions include aplasia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cerubidine side effects in 13 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29
Patient: 13 year old male
Reactions: Fungal Infection, Bacterial Infection, Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cerubidine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Methotrexate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-09
End date: 2011-10-03
Kidrolase
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Hydrocortisone ^upjohn^
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Vincristine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Other drugs received by patient: Bactrim DS; Amikacin; Fasturtec; Prednisolone; Tazobactam
Possible Cerubidine side effects in 13 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23
Patient: 13 year old male
Reactions: Klebsiella Infection, Abdominal Pain, Diarrhoea, Fungal Infection, Blood Culture Positive, Bacterial Infection, Aplasia, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-09
End date: 2011-10-03
Hydrocortisone
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Cerubidine
Dosage: intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Vincristine Sulfate
Dosage: in accordance with the cycle,intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Cytarabine
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
(Kidrolase)
Dosage: intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Other drugs received by patient: Bactrim; (Amiklin / 00391001 / ); Tazobactam; Solupred / 00016217 / ); Fasturtec
Possible Cerubidine side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22
Patient: 55 year old male
Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 450 mug, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-03-02
Primperan TAB
Dosage: unk
Indication: Vomiting
Start date: 2012-02-24
End date: 2012-03-01
Cytarabine
Dosage: 1 g, qd
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Cerubidine
Dosage: 120 mg, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Other drugs received by patient: Gaviscon; Acetaminophen; Perikabiven; Ondansetron; Tramadol Hydrochloride; Hydrea; Kabiven; Vancomycin; Folic Acid; Lasix; Ceftriaxone Sodium; Acyclovir; Rovamycine / 00074401 /; Piperacilline Panpharma; Acetaminophen; Tiorfan
Possible Cerubidine side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-18
Patient: 55 year old male
Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cerubidine
Dosage: 120 mg, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Primperan TAB
Dosage: unk
Indication: Vomiting
Start date: 2012-02-24
End date: 2012-03-01
Cytarabine
Dosage: 1 g, qd
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Neupogen
Dosage: 450 mug, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-03-02
Other drugs received by patient: Vancomycin; Acyclovir; Rovamycine / 00074401 /; Hydrea; Perikabiven; Ceftriaxone Sodium; Tiorfan; Kabiven; Folic Acid; Lasix; Ondansetron; Acetaminophen; Gaviscon; Acetaminophen; Piperacilline Panpharma; Tramadol Hydrochloride
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Generalised Oedema, Ascites, Pericardial Effusion, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Dosage: 780 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
Cytarabine
Dosage: 25 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Methotrexate
Dosage: 12 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine
Dosage: 1.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Kidrolase
Dosage: 4800 iu, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Aplasia, Stomatococcal Infection, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Spleen Disorder, Oral Disorder, Sepsis, Hypoxia, Acute Respiratory Distress Syndrome, Pleural Effusion, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 25 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cerubidine
Dosage: 31 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Dosage: 12 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine
Dosage: 1.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Kidrolase
Dosage: 4800 iu, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cyclophosphamide
Dosage: 780 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-02
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Ascites, Pericardial Effusion, Generalised Oedema, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kidrolase
Dosage: 4800 iu, unk
Start date: 2011-10-06
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Dosage: 25 mg, unk
Start date: 2011-10-10
End date: 2011-10-14
Cyclophosphamide
Dosage: 780 mg, unk
Start date: 2011-10-06
Vincristine Sulfate
Dosage: 1.2 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-10-13
End date: 2011-10-21
Methotrexate
Dosage: 12 mg, unk
Start date: 2011-10-03
End date: 2011-10-14
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-31
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Oral Disorder, Sepsis, Pleural Effusion, Hypoxia, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 1.2 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Dosage: 25 mg, unk
Start date: 2011-10-10
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Dosage: 12 mg, unk
Start date: 2011-10-03
End date: 2011-10-14
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Dosage: 780 mg, unk
Start date: 2011-10-06
Kidrolase
Dosage: 4800 iu, unk
Start date: 2011-10-06
End date: 2011-10-14
|